Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
No cancellation fees
Addressing the hormonal picture isn't a shortcut
In studies with rats and mice, Saxenda and medicines that work like Saxenda caused thyroid tumors, including thyroid cancer
This triple-action mechanism distinguishes it from existing approved agents such as semaglutide (GLP-1 only) or tirzepatide (GLP-1/GIP dual agonist)
Frequently Asked Questions Is the pen format chemically different from the vial
A French study analyzing data from the national health insurance system found that current use of GLP-1 RAs was associated with a 46% increased risk of all thyroid cancers and a 78% increased risk of medullary thyroid cancer after one to three years of use
